Keywords: Tumors, Machine Learning/Artificial Intelligence, Deep LearningNF2-L in meningiomas is a relevant indicator of prognosis. NF2-L is one of the most common genetic mutations in meningiomas. As a result of that situation, developing a non-invasive approach may assist the current clinical procedures. To our knowledge, some studies try to predict NF2-L using MRI modalities but either they use registration or performed using the modalities of MRI that are not in default MRI scanning procedures. Hence, the solutions that they provide are not clinically feasible. In this study, we aim to develop new approaches that are capable to implement directly into clinical procedures.[1]
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords